Literature DB >> 16757349

Characterization of RERG: an estrogen-regulated tumor suppressor gene.

Megan D Key1, Douglas A Andres, Channing J Der, Gretchen A Repasky.   

Abstract

RERG (Ras-related and estrogen-regulated growth inhibitor), a gene that encodes a small GTP binding and hydrolyzing protein (GTPase) of the Ras superfamily, was originally identified in gene microarray analysis as a gene of which expression is down-regulated in estrogen receptor (ER)-negative breast tumors. Subsequently, RERG mRNA was detected in ER-positive breast tumor-derived cell lines, but not in any of the ER-negative cell lines examined. Furthermore, a comparison of matched tumor and normal tissue samples suggests that RERG expression is lost in kidney, breast, ovary, and colon tumors. The lack of RERG expression in many highly aggressive breast carcinomas suggests that RERG plays an inhibitory role in cell growth and division. In fact, growth of breast tumor cells was inhibited by overexpression of RERG both in vitro and in vivo. In this chapter, we summarize the reagents and approaches used to characterize RERG gene expression, to demonstrate that RERG functions as a GTP/GDP molecular switch, and to characterize the growth inhibitory activity of RERG.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16757349     DOI: 10.1016/S0076-6879(05)07041-2

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  7 in total

1.  Transcript response of soft coral (Scleronephthya gracillimum) on exposure to polycyclic aromatic hydrocarbons.

Authors:  Seonock Woo; Aekyung Lee; Vianney Denis; Chaolun A Chen; Seungshic Yum
Journal:  Environ Sci Pollut Res Int       Date:  2013-07-06       Impact factor: 4.223

2.  Seasonal changes in patterns of gene expression in avian song control brain regions.

Authors:  Christopher K Thompson; John Meitzen; Kirstin Replogle; Jenny Drnevich; Karin L Lent; Anne Marie Wissman; Federico M Farin; Theo K Bammler; Richard P Beyer; David F Clayton; David J Perkel; Eliot A Brenowitz
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

3.  MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG/Ras/ERK signaling axis.

Authors:  Jar-Yi Ho; Ren-Jun Hsu; Jui-Ming Liu; Szu-Chi Chen; Guo-Shiou Liao; Hong-Wei Gao; Cheng-Ping Yu
Journal:  Oncotarget       Date:  2017-04-04

4.  RERG suppresses cell proliferation, migration and angiogenesis through ERK/NF-κB signaling pathway in nasopharyngeal carcinoma.

Authors:  Weilin Zhao; Ning Ma; Shumin Wang; Yingxi Mo; Zhe Zhang; Guangwu Huang; Kaoru Midorikawa; Yusuke Hiraku; Shinji Oikawa; Mariko Murata; Kazuhiko Takeuchi
Journal:  J Exp Clin Cancer Res       Date:  2017-06-28

5.  The functional genome of CA1 and CA3 neurons under native conditions and in response to ischemia.

Authors:  Dieter Newrzella; Payam S Pahlavan; Carola Krüger; Christine Boehm; Oliver Sorgenfrei; Helmut Schröck; Gisela Eisenhardt; Nadine Bischoff; Gerhard Vogt; Oliver Wafzig; Moritz Rossner; Martin H Maurer; Holger Hiemisch; Alfred Bach; Wolfgang Kuschinsky; Armin Schneider
Journal:  BMC Genomics       Date:  2007-10-15       Impact factor: 3.969

6.  Rasl11b knock down in zebrafish suppresses one-eyed-pinhead mutant phenotype.

Authors:  Guillaume Pézeron; Guillaume Lambert; Thomas Dickmeis; Uwe Strähle; Frédéric M Rosa; Philippe Mourrain
Journal:  PLoS One       Date:  2008-01-16       Impact factor: 3.240

Review 7.  Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma.

Authors:  Yuanbo Kang; Weihan He; Caiping Ren; Jincheng Qiao; Qiuyong Guo; Jingyu Hu; Hongjuan Xu; Xingjun Jiang; Lei Wang
Journal:  Signal Transduct Target Ther       Date:  2020-10-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.